To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene APOL4TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
144 supporting clones for gene APOL4 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AY014915   .a 1 to 3225 1 to 3227 V111E S112F S113P N114Q Q115I ... tiling clone,   3227/3227
(100 %)
8 diff
(99.8 %id)
NM_145660.1   .a 1 to 3226 1 to 3228 V111E S112F S113P N114Q Q115I ... RefSeq,   3228/3228
(100 %)
1 diff
(100.0 %id)
AK311506 Prostate .a 28 to 1173 1 to 1146 I9V V12L tiling clone,   1146/1146
(100 %)
9 diff
(99.3 %id)
DA865632 Prostate .a 29 to 537 2 to 510   capped   509/509
(100 %)
7 diff
(98.7 %id)
DA869518 Prostate .a 29 to 570 2 to 545   capped   544/544
(100 %)
11 diff
(98.0 %id)
DA541754 lung .a 31 to 620 2 to 593 I9V V12L V111E S112F S113P ... capped   592/592
(100 %)
9 diff
(98.5 %id)
AK313637 trachea .a 64 to 1279 1 to 1216   tiling clone,   1216/1216
(100 %)
5 diff
(99.6 %id)
DB230518 trachea .a 65 to 660 2 to 597   capped   596/596
(100 %)
3 diff
(99.5 %id)
DA869528 Prostate .a 121 to 663 2 to 546 I9V V12L V111E S112F S113P ... capped   545/545
(100 %)
7 diff
(98.8 %id)
DN997475 breast cancer, Mammary gland (cancer tissue) .a 142 to 768 8 to 635 I9V V12L V111E S112F S113P ...     628/635
(98 %)
11 diff
(98.3 %id)
BE799424 lung, small cell carcinoma .a 373 to 1188 23 to 839       817/967
(84 %)
51 diff
(94.8 %id)
BU198645   .a 492 to 1253 1 to 765       765/1061
(72 %)
36 diff
(96.7 %id)
DA007814   .a 515 to 1066 2 to 555   capped   554/554
(100 %)
3 diff
(99.5 %id)
DA867518 Prostate .a 574 to 1102 2 to 530   capped   529/529
(100 %)
2 diff
(99.7 %id)
BX450830 placenta .a 646 to 1478 838 to 1       838/885
(94 %)
26 diff
(97.1 %id)
AV684062 hepatocellular carcinoma .a 684 to 1078 1 to 386       386/387
(99 %)
7 diff
(98.2 %id)
BX450992 placenta .a 719 to 1478 759 to 1       759/908
(83 %)
35 diff
(96.2 %id)
FN158763 breast carcinoma .a 766 to 849 1 to 83       83/83
(100 %)
2 diff
(97.6 %id)
BQ370998 prostate_normal .a 1116 to 1528 412 to 1       412/412
(100 %)
11 diff
(97.4 %id)
FN088358 breast carcinoma .a 1147 to 1213 1 to 66       66/67
(98 %)
3 diff
(95.6 %id)
AA213434   .a 1206 to 1287 390 to 478       451/485
(92 %)
38 diff
(92.2 %id)
BX458578 placenta .a 1287 to 2194 906 to 6       901/906
(99 %)
0 diff
(100 %id)
H27161 breast .a 1300 to 1668 1 to 373   tiling clone,   373/393
(94 %)
8 diff
(98.0 %id)
BX464530 placenta .a 1374 to 2135 797 to 37       761/797
(95 %)
0 diff
(100 %id)
AA025373 heart .a 1613 to 1938 1 to 329   fully sequenced,   329/329
(100 %)
2 diff
(99.4 %id)
AW630982 2 pooled high-grade transitional celltumors, genitourinary tract .a 1614 to 2041 22 to 449       428/449
(95 %)
6 diff
(98.7 %id)
BY997091   .a 1617 to 2197 21 to 595       575/595
(96 %)
6 diff
(99.0 %id)
DB329837 Prostate .a 1675 to 2267 589 to 1       589/589
(100 %)
11 diff
(98.2 %id)
AI052532   .a 1718 to 2265 548 to 6       543/548
(99 %)
0 diff
(100 %id)
AW247858 lung, small cell carcinoma .a 1728 to 2265 549 to 12   AAA   538/538
(100 %)
5 diff
(99.1 %id)
AI278003 placenta .a 1733 to 2210 479 to 8       472/479
(98 %)
0 diff
(100 %id)
AW148694 brain, tumor, 5 pooled (see description) .a 1737 to 2197 467 to 13   AAA   455/455
(100 %)
6 diff
(98.7 %id)
AI168715 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1752 to 2235 482 to 1       482/482
(100 %)
3 diff
(99.4 %id)
AA034516 uterus .a 1761 to 2266 506 to 1       506/506
(100 %)
2 diff
(99.7 %id)
AI191223 lung .a 1775 to 2265 497 to 8   tiling clone,   490/497
(98 %)
0 diff
(100 %id)
AI810804 Prostate .a 1794 to 2265 472 to 1       472/472
(100 %)
1 diff
(99.8 %id)
AW304793 brain, three pooled meningiomas .a 1801 to 2251 445 to 1       445/445
(100 %)
10 diff
(97.8 %id)
AA962385 carcinoid, lung .a 1811 to 2212 396 to 1       396/396
(100 %)
7 diff
(98.3 %id)
AW439563 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 1815 to 2264 446 to 1       446/446
(100 %)
12 diff
(97.4 %id)
AA974092 pooled germ cell tumors .a 1883 to 2235 353 to 1       353/353
(100 %)
0 diff
(100 %id)
AA025374 heart .a 1908 to 2268 358 to 1   fully sequenced,   358/358
(100 %)
10 diff
(97.3 %id)
AA225582   .a 1956 to 2327 7 to 379       373/379
(98 %)
3 diff
(99.3 %id)
BE731647 choriocarcinoma, placenta .a 2006 to 2813 1 to 797       797/808
(98 %)
20 diff
(97.6 %id)
AI669093 Prostate .a 2046 to 2265 219 to 1       219/219
(100 %)
2 diff
(99.1 %id)
AI676020 Prostate .a 2046 to 2265 220 to 1       220/220
(100 %)
1 diff
(99.6 %id)
AW627682 2 pooled high-grade transitional celltumors, genitourinary tract .a 2808 to 3226 423 to 5   tiling clone,   419/423
(99 %)
0 diff
(100 %id)
AA213506   .a 2902 to 3224 327 to 1       327/379
(86 %)
12 diff
(96.9 %id)
DC392154 stomach .b 1 to 519 2 to 520   tiling clone,   520/520
(100 %)
4 diff
(99.3 %id)
DC426654 stomach .b 1691 to 2278 588 to 1   tiling clone,   588/588
(100 %)
0 diff
(100 %id)
DC362087 Kidney .c 1 to 566 2 to 567   tiling clone,   567/568
(99 %)
6 diff
(99.0 %id)
DC383429 Prostate .c 37 to 586 1 to 550   tiling clone,   550/550
(100 %)
3 diff
(99.5 %id)
AK290466 brain .c 92 to 1822 1 to 1733 V108E S109F S110P N111Q Q112I ... tiling clone,   1733/1733
(100 %)
14 diff
(99.2 %id)
DC350511 brain .c 92 to 664 1 to 573       573/573
(100 %)
4 diff
(99.4 %id)
DC383756 Prostate .c 96 to 655 1 to 560   tiling clone,   560/560
(100 %)
1 diff
(99.9 %id)
DC370766   .c 298 to 803 1 to 506       506/506
(100 %)
4 diff
(99.3 %id)
AY014914   .d 1 to 3414 1 to 3417 V108E S109F S110P N111Q Q112I ... tiling clone,   3417/3417
(100 %)
7 diff
(99.8 %id)
NM_030643.3   .d 1 to 3415 1 to 3417 V108E S109F S110P N111Q Q112I ... RefSeq,   3417/3417
(100 %)
1 diff
(100.0 %id)
DA872824 Prostate .d 29 to 608 2 to 581   tiling clone, capped   580/582
(99 %)
1 diff
(99.9 %id)
DA875870 Prostate .d 29 to 600 2 to 573   capped   572/572
(100 %)
4 diff
(99.4 %id)
DA874157 Prostate .d 66 to 633 2 to 569   capped   568/570
(99 %)
6 diff
(99.0 %id)
DA956649 Spleen .d 260 to 801 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
DA749031   .d 282 to 855 2 to 575 K81X M94L capped   574/574
(100 %)
2 diff
(99.7 %id)
AK312716 brain .d 291 to 1468 1 to 1180 R102S V108E S109F S110P N111Q ...     1180/1180
(100 %)
11 diff
(99.1 %id)
DA012937 adrenal gland .d 292 to 870 2 to 580 exact capped   579/579
(100 %)
0 diff
(100 %id)
DA778054 brain .d 292 to 854 2 to 566 R102S V108E S109F S110P N111Q ... capped   565/565
(100 %)
6 diff
(99.0 %id)
DB122311 thymus .d 292 to 866 2 to 578 V108E S109F S110P N111Q Q112I ... capped   577/577
(100 %)
3 diff
(99.5 %id)
DA594218 lung .d 299 to 866 2 to 571 V108E S109F S110P N111Q Q112I ... capped   570/570
(100 %)
5 diff
(99.2 %id)
DA880300 Prostate .d 301 to 855 2 to 568 V11X G12R V13G Q14A Q15A ... capped   576/567
(101 %)
60 diff
(89.5 %id)
DB196527 trachea .d 303 to 853 2 to 554 V108E S109F S110P N111Q Q112I ... capped   553/553
(100 %)
4 diff
(99.3 %id)
DB210796 trachea .d 303 to 867 2 to 565 exact capped   564/564
(100 %)
3 diff
(99.5 %id)
DB257672 uterus .d 303 to 878 2 to 577 K30R capped   576/576
(100 %)
1 diff
(99.9 %id)
DA379091 thalamus .d 304 to 942 2 to 640 exact capped   639/639
(100 %)
1 diff
(99.9 %id)
DA889164   .d 304 to 855 2 to 555 V108E S109F S110P N111Q Q112I ... capped   554/554
(100 %)
5 diff
(99.1 %id)
DB166689 kidney, tumor tissue .d 306 to 850 2 to 547 V11X G12R V13G Q14A Q15A ... capped   546/546
(100 %)
4 diff
(99.3 %id)
BE799699 lung, small cell carcinoma .d 311 to 1192 6 to 894 K121N A122G S123F C124A H125V ...     898/963
(93 %)
99 diff
(89.8 %id)
CF596050 Stomach, adenocarcinoma .d 311 to 1059 1 to 768 V108E S109F S110P N111Q Q112I ...     772/773
(99 %)
37 diff
(95.3 %id)
BM194654 leukopheresis .d 314 to 857 1 to 544 N111X     544/544
(100 %)
3 diff
(99.5 %id)
DB271796 uterus .d 323 to 891 2 to 572 V108E S109F S110P N111Q Q112I ... capped   571/571
(100 %)
3 diff
(99.5 %id)
DB123652 thymus .d 325 to 955 2 to 634 V108E S109F S110P N111Q Q112I ... capped   633/633
(100 %)
4 diff
(99.4 %id)
BX283290 choriocarcinoma, placenta .d 326 to 839 1 to 514 exact     514/514
(100 %)
1 diff
(99.9 %id)
BI914645 brain .d 326 to 1092 1 to 766 L106*     766/767
(99 %)
10 diff
(98.7 %id)
AW247246.
matches multiple genes
lung, small cell carcinoma .d 327 to 884 10 to 567 exact available from MGC, Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base), also hits gene UQCR11andMBD3 558/567
(98 %)
6 diff
(99.0 %id)
BC004150 Lung, small cell carcinoma .d 327 to 2454 1 to 2128 exact available from MGC, AAA   2128/2128
(100 %)
3 diff
(99.9 %id)
BC017313 Placenta, choriocarcinoma .d 327 to 2454 1 to 2128   available from MGC, AAA   2128/2128
(100 %)
0 diff
(100 %id)
BC010131 Placenta, choriocarcinoma .d 327 to 2454 1 to 2128 exact tiling clone, available from MGC, AAA   2128/2128
(100 %)
0 diff
(100 %id)
DA858454 placenta .d 327 to 896 2 to 573 V108E S109F S110P N111Q Q112I ... capped   572/572
(100 %)
4 diff
(99.4 %id)
DA949098 Spleen .d 327 to 862 2 to 539 V108E S109F S110P N111Q Q112I ... capped   538/538
(100 %)
5 diff
(99.1 %id)
TI_57240761   .d 328 to 1092 41 to 804 L106*     764/805
(94 %)
15 diff
(98.2 %id)
AL601336   .d 335 to 733 1 to 399       399/399
(100 %)
1 diff
(99.8 %id)
AK225696 synovial membrane (knee) .d 340 to 2374 1 to 2031 V108E S109F S110P N111Q Q112I ...     2031/2031
(100 %)
18 diff
(99.2 %id)
DA969428 stomach .d 341 to 907 2 to 569 E71G capped   568/568
(100 %)
3 diff
(99.5 %id)
BE902918 choriocarcinoma, placenta .d 344 to 1197 1 to 860 L106W     860/1135
(75 %)
44 diff
(96.2 %id)
BE900268 choriocarcinoma, placenta .d 345 to 1148 1 to 793 F62L V63C R64V V65W A66L ... available from MGC,   793/794
(99 %)
14 diff
(98.3 %id)
BE900392 choriocarcinoma, placenta .d 346 to 1181 1 to 836 exact available from MGC,   836/851
(98 %)
15 diff
(98.3 %id)
AF305226 placenta .d 349 to 1468 1 to 1119 V108F S109P S110Q N111I Q112R ...     1119/1119
(100 %)
1 diff
(100.0 %id)
BM194063 leukopheresis .d 349 to 821 1 to 474 F105V L106F K107E V108S S109F ...     474/474
(100 %)
2 diff
(99.6 %id)
DB187494 liver, tumor tissue .d 349 to 920 2 to 575 V108E S109F S110P N111Q Q112I ... capped   574/574
(100 %)
3 diff
(99.5 %id)
DA619213   .d 354 to 940 2 to 590 V108E S109F S110P N111Q Q112I ... capped   589/589
(100 %)
3 diff
(99.5 %id)
DA619815   .d 354 to 940 2 to 590 V108E S109F S110P N111Q Q112I ... capped   589/589
(100 %)
3 diff
(99.5 %id)
DB117699 thymus .d 354 to 907 2 to 555 exact capped   554/554
(100 %)
0 diff
(100 %id)
CR607178 placenta .d 362 to 2389 1 to 2028 exact     2028/2028
(100 %)
0 diff
(100 %id)
BX458579 placenta .d 362 to 1318 1 to 948 V108E S109F S110P N111Q Q112I ...     948/951
(99 %)
26 diff
(97.3 %id)
BX464531 placenta .d 362 to 1147 1 to 787 E28X K43X K50X V108E S109F ...     787/787
(100 %)
6 diff
(99.3 %id)
AV691405 hepatocellular carcinoma .d 363 to 709 1 to 338       338/338
(100 %)
6 diff
(98.3 %id)
DA745070   .d 367 to 944 2 to 582 V108E S109F S110P N111Q Q112I ... capped   581/581
(100 %)
5 diff
(99.2 %id)
AK290777   .d 369 to 1529 1 to 1163 V108E S109F S110P N111Q Q112I ...     1163/1163
(100 %)
8 diff
(99.4 %id)
DC428182   .d 369 to 935 1 to 569 V108E S109F S110P N111Q Q112I ...     569/569
(100 %)
3 diff
(99.5 %id)
DA919489 small intestine .d 374 to 946 2 to 574 exact capped   573/573
(100 %)
1 diff
(99.9 %id)
DB206652 trachea .d 374 to 955 2 to 585 exact capped   584/584
(100 %)
3 diff
(99.5 %id)
DN996634 breast cancer, Mammary gland (cancer tissue) .d 377 to 1118 1 to 742 exact     742/742
(100 %)
6 diff
(99.2 %id)
DA583493 lung .d 386 to 931 2 to 545 K97R E98T Q99A Q100V F101* capped   544/544
(100 %)
1 diff
(99.9 %id)
CR456380   .d 411 to 1630 1 to 1222 V108E S109F S110P N111Q Q112I ...     1222/1222
(100 %)
8 diff
(99.4 %id)
BE902126 choriocarcinoma, placenta .d 412 to 1208 8 to 800 Q15R N16K H17T P18I G19Q ...     793/892
(88 %)
22 diff
(97.6 %id)
BI051603 placenta_normal .d 419 to 703 10 to 293       284/293
(96 %)
8 diff
(97.3 %id)
CU013226 Synthetic constructs .d 424 to 1465 20 to 1063 V108E S109F S110P N111Q Q112I ...     1044/1078
(96 %)
15 diff
(98.7 %id)
CU012938 Synthetic constructs .d 424 to 1476 20 to 1074 V108E S109F S110P N111Q Q112I ...     1055/1081
(97 %)
19 diff
(98.3 %id)
DB348124 trachea .d 1911 to 2454 538 to 1       538/538
(100 %)
8 diff
(98.6 %id)
CB529457 Aveolar Macrophage, lung .d 2642 to 3413 788 to 19   AAA   770/770
(100 %)
9 diff
(98.9 %id)
BU584459 sm intestine .d 2714 to 3310 606 to 1       606/606
(100 %)
20 diff
(96.7 %id)
BU584151 breast tumor .d 2773 to 3375 603 to 1       603/603
(100 %)
6 diff
(99.1 %id)
BU584714   .d 2775 to 3369 1 to 595       595/595
(100 %)
6 diff
(99.0 %id)
BY994994   .d 2776 to 3413 683 to 46   AAA Submitted on the opposite strand 638/638
(100 %)
6 diff
(99.1 %id)
AA774194   .d 2899 to 3310 412 to 1     Submitted on the opposite strand 412/412
(100 %)
4 diff
(99.1 %id)
AA716622 heart .d 2916 to 3413 498 to 1       498/498
(100 %)
10 diff
(98.0 %id)
AI057161 brain, glioblastoma (pooled) .d 2962 to 3415 455 to 2   tiling clone,   454/455
(99 %)
0 diff
(100 %id)
AA716534 heart .d 2973 to 3278 303 to 1       303/303
(100 %)
7 diff
(97.7 %id)
BU584871 Prostate .d 3034 to 3422 1 to 385       385/393
(97 %)
9 diff
(97.8 %id)
AA225603   .d 3068 to 3413 381 to 37   AAA   345/345
(100 %)
1 diff
(99.8 %id)
BG941675 blood .d 3097 to 3413 1 to 317       317/324
(97 %)
3 diff
(99.1 %id)
BU584513   .d 3116 to 3413 1 to 298   AAA   298/298
(100 %)
0 diff
(100 %id)
BM720871 eye, fetal eye .d 3118 to 3414 67 to 363   fully sequenced, AAA   297/363
(81 %)
4 diff
(98.9 %id)
BM676968 eye, fetal eye .d 3159 to 3413 273 to 19   fully sequenced, AAA   255/255
(100 %)
0 diff
(100 %id)
AI820099 pooled .d 3176 to 3413 258 to 21   AAA   238/238
(100 %)
3 diff
(98.8 %id)
AI742559 pooled .d 3179 to 3413 255 to 21   AAA   235/238
(98 %)
2 diff
(99.2 %id)
BF090960 ovary .d 3182 to 3376 1 to 195       195/195
(100 %)
4 diff
(98.0 %id)
AI131026 heart .d 3185 to 3682 512 to 15   tiling clone, AAA   498/498
(100 %)
2 diff
(99.6 %id)
AA716363 heart .d 3232 to 3413 181 to 1       181/181
(100 %)
2 diff
(98.9 %id)
BC006276 Placenta, choriocarcinoma .e 1 to 844 1 to 844 exact tiling clone, available from MGC, AAA   844/844
(100 %)
0 diff
(100 %id)
BE900719 choriocarcinoma, placenta .e 20 to 509 1 to 490   available from MGC,   490/490
(100 %)
0 diff
(100 %id)
CV029964 mixed .e 334 to 656 1 to 323       323/499
(64 %)
1 diff
(99.8 %id)
TI_1948097607   .e 334 to 656 129 to 451       323/1082
(29 %)
7 diff
(99.4 %id)
DC414277 trachea .f 1 to 511 2 to 513 L31* tiling clone,   513/513
(100 %)
6 diff
(98.9 %id)
DA531325 brain .f 293 to 827 2 to 536   capped   535/535
(100 %)
1 diff
(99.9 %id)
DA961375 Spleen .f 336 to 907 2 to 573   tiling clone, capped   572/572
(100 %)
0 diff
(100 %id)
DC388877 small intestine .g 1 to 575 1 to 575 exact tiling clone,   575/575
(100 %)
5 diff
(99.2 %id)
DB117798 thymus .h 1 to 560 2 to 561 Y2N V9A tiling clone, capped   560/560
(100 %)
2 diff
(99.7 %id)
DC383363 Prostate .i 1 to 542 2 to 543 exact tiling clone,   543/543
(100 %)
4 diff
(99.3 %id)
AV687413 hepatocellular carcinoma Gene APOL4, variant not shown         Suspected internal deletion, this clone was ignored    
AV690831 hepatocellular carcinoma Gene APOL4, variant not shown         Suspected internal deletion, this clone was ignored    
DB257032 uterus Gene APOL4, variant not shown       capped This clone was ignored    
DB351464 uterus Gene APOL4, variant not shown         This clone was ignored    
DB272857 uterus Gene APOL4, variant not shown       capped Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DC